Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.88 |
| ▸ | MMP1 | P03956 | 1/20 | 0.88 |
| ▸ | FOS | P01100 | 1/20 | 0.62 |
| ▸ | TTR | P02766 | 1/20 | 0.62 |
| ▸ | JUN | P05412 | 1/20 | 0.62 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.62 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.62 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (+)-Secoisolariciresinol SCHEMBL12427083 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL30605875 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL29363814 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL325398 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL30334899 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL31677395 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL29617981 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL20402961 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| (+)-Secoisolariciresinol SCHEMBL21028109 | 0.94 | CYP3A4 (1.00) | CYP3A4MMP1FOSTTRJUN | |
| SCHEMBL29838368 | 0.89 | CYP3A4 (0.91) | CYP3A4MMP1FOSTTRJUN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024205200-A1 | ELECTROLYTE FOR ANODE-FREE LITHIUM METAL BATTERY AND ANODE-FREE LITHIUM METAL BATTERY COMPRISING SAME | 삼성에스디아이주식회사 | 2024-10-03 | — | — | WO | claimed |
| WO-2024196936-A2 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| US-20240322244-A1 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2024-09-26 | — | — | US | claimed |
| CN-118352622-A | Electrolyte for non-anode battery | 通用汽车环球科技运作有限责任公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117393847-A | Gel polymer electrolyte with sulfolane additive | 通用汽车环球科技运作有限责任公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116468645-B | Antagonistic hyperspectral multispectral remote sensing fusion method | 吉林大学 | 2023-09-15 | — | — | CN | claimed |
| CN-116565304-A | Lithiation additive for solid state battery comprising gel electrolyte | 通用汽车环球科技运作有限责任公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116468645-A | Antagonistic hyperspectral multispectral remote sensing fusion method | 吉林大学 | 2023-07-21 | — | — | CN | claimed |
| EP-4100953-A1 | METHODS FOR DETECTING AND CHARACTERIZING MICROSATELLITE INSTABILITY WITH HIGH THROUGHPUT SEQUENCING | Sophia Genetics S.A. (CH) | 2022-12-14 | — | — | EP | claimed |
| US-20220223226-A1 | METHODS FOR DETECTING AND CHARACTERIZING MICROSATELLITE INSTABILITY WITH HIGH THROUGHPUT SEQUENCING | SOPHIA GENETICS S.A. (CH) | 2022-07-14 | — | — | US | claimed |
| CN-122059874-A | Nicotinamide derivative containing (-) -menthol group with antifungal activity, preparation method and application thereof | 韩山师范学院 | 2026-05-19 | — | — | CN | disclosed |
| US-20260134958-A1 | DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODS | TEMPUS AI INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-121351420-B | ERLTC high-resolution numerical simulation prediction method, medium and program product based on IDII and DMSI fusion driving | 中国气象科学研究院 | 2026-02-24 | — | — | CN | disclosed |
| CN-121351420-B | ERLTC high-resolution numerical simulation prediction method, medium and program product based on IDII and DMSI fusion driving | 中国气象科学研究院 | 2026-02-24 | — | — | CN | disclosed |
| CN-121351420-A | ERLTC high-resolution numerical simulation prediction method, medium and program product based on IDII and DMSI fusion driving | 中国气象科学研究院 | 2026-01-16 | — | — | CN | disclosed |
| WO-2022063531-A1 | ELECTROCHEMICAL PROCESS FOR FORMING A SOLID ELECTROLYTE | IMEC VZW (BE) | 2022-03-31 | — | — | WO | disclosed |
| EP-3974562-A1 | ELECTROCHEMICAL PROCESS FOR FORMING A SOLID ELECTROLYTE | Imec VZW (BE) | 2022-03-30 | — | — | EP | disclosed |
| EP-3963591-A1 | TECHNIQUES FOR GENERATING ENCODED REPRESENTATIONS OF COMPOUNDS | Waters Technologies Ireland Limited (IE) | 2022-03-09 | — | — | EP | disclosed |
| CN-114026650-A | Techniques for generating a coded representation of a compound | 沃特世科技爱尔兰有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-110577524-B | Kinase selective inhibitor | 北京大学深圳研究生院 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260134958-A1 | DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODS | BRCA1, TP53, SMN1; SMN2 | CYP3A4 3386/4885MMP1 4693/4885FOS 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.